Open original FDA record ↗Recall record
- FDA identifier
- Z-0738-2022
- Company in FDA record
- NeuMoDx Molecular Inc
- FDA record creation date
- Mar 8, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.
Source facts
- Action
- Customers were contacted by phone 21 Jan 2022 and sent a follow up email with instructions to stop using Lot 116305 S/L02, discard remaining inventory, and review all SARS-CoV-2 positive results previously obtained using the affected product lot to exclude erroneous diagnosis and treatment. Customers are to forward this information to all individuals and departments within their organization using the affected product. If you have any questions regarding this notice, please contact QIAGEN Technical Services at 1-800-362-7737 or techservice-na@qiagen.com.
- Initiated
- 2022-01-21
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states of FL, MD, MI, NY.
- Recall number
- Z-0738-2022
- Recall status
- Open, Classified
- CDRH record ID
- 192182
- FDA record created
- 2022-03-08
- Recall event number
- 89675